# Evaluation of Von Willebrand Factor as a Marker For Early Diagnosis of Acute Respiratory Distress Syndrome (A.R.D.S) in Comparison to Interleukin 6 [IL-6]

> **NCT04317469** · — · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- ARDS, Human

## Interventions

- **DIAGNOSTIC_TEST:** VWF measurement

## Key facts

- **NCT ID:** NCT04317469
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-21
- **Primary completion:** 2021-03-20
- **Final completion:** 2021-09-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04317469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04317469, "Evaluation of Von Willebrand Factor as a Marker For Early Diagnosis of Acute Respiratory Distress Syndrome (A.R.D.S) in Comparison to Interleukin 6 [IL-6]". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT04317469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*